Publication Details

Pubmed21163924
Title: A mechanistic rationale for MEK inhibitor therapy in myeloma based on blockade of MAF oncogene expression.
Year: 2010
DOI: https://doi.org/10.1182/blood-2010-04-278788
First Author: Annunziata
Experimental setup: affinity chromatography technology (Biogrid)
Throughput: Low Throughput (Biogrid)

Interactions

1 interaction
InteractorPartnerSourcesLink
FOS_HUMANMAF_HUMANBioGRIDdetails